CIK: 1578074 - Address: C/O Pacira Biosciences, Inc., 5401 West Kennedy Boulevard, Suite 890, Tampa, FL 33609
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112012122306628
P%wins5050100100505067
S%ret111-3-10-23-13-340-17
S%wins100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/12/23 16:16
6/8/23
PCRXPacira Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKronenfeld Mark A.FLDM.d44929.9001551818D
6/12/23 16:16
6/8/23
PCRXPacira Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsKronenfeld Mark A.FLDS.d-55637.040-15-4618D
3/8/19 16:17
3/6/19
PCRXPacira Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsKronenfeld Mark A.NJDP6638.97022010D
8/30/18 16:34
8/28/18
PCRXPacira Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsKronenfeld Mark A.NJDP4544.6101139D
11/13/17 20:03
11/10/17
PCRXPacira Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsKronenfeld Mark A.NJDP4241.6001177D
6/8/16 19:04
6/6/16
PCRXPacira Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsKronenfeld Mark A.NJDS-4246.9533-1-233D-42-39-25-4-209100-3-10-23-13-34
11/4/14 19:42
11/3/14
PCRXPacira Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsKronenfeld Mark A.NJDP7790.48331852D4757724-6-10-8-12-14-3-2618-23-38
9/13/13 19:26
9/11/13
PCRXPacira Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKronenfeld Mark A.NJDP3737.0171New1D35911327261243334352683169

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact